Specifically, we found that oxidative phosphorylation (OXPHOS) acts as a critical driver of T cell dysfunction in CM and AM, corroborating recent findings of a subset of CD8+ T cells characterized by high OXPHOS activity and impaired cytotoxicity within the tumor milieu [50,51]. The gene discussed is CD8A; the disease is neoplasm.